Feedback / Questions
Trodelvy (sacituzumab govitecan-hziy) - Gilead
Enhertu (fam-trastuzumab deruxtecan-nxki) - Daiichi Sankyo, AstraZeneca
Kisqali (ribociclib) - Novartis
Ibrance (palbociclib) - Pfizer
https://www.esmo.org/guidelines/living-guidelines/esmo-living-guideline-metastatic-breast-cancer
Aug 25, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next